{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:38:16Z","timestamp":1790199496855,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973097,82273687"],"award-info":[{"award-number":["81973097,82273687"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703269"],"award-info":[{"award-number":["81703269"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173568"],"award-info":[{"award-number":["82173568"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017961","name":"Health Commission of Heilongjiang Province","doi-asserted-by":"publisher","award":["20221212060609"],"award-info":[{"award-number":["20221212060609"]}],"id":[{"id":"10.13039\/100017961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"publisher","award":["LH2023H054"],"award-info":[{"award-number":["LH2023H054"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.urolonc.2024.01.018","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T21:03:59Z","timestamp":1709067839000},"page":"133-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Survivin as a potential biomarker in the diagnosis of bladder cancer: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"42","author":[{"given":"Zhiren","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhe","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanyu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiru","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengzhong","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongkun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.urolonc.2024.01.018_bib0001","first-page":"1003","article-title":"National tumor quality control center bladder cancer quality control expert committee. quality control indicators for standardized diagnosis and treatment of bladder cancer in China (2022 version)","volume":"44","year":"2022","journal-title":"Chin J Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.01.018_bib0002","doi-asserted-by":"crossref","first-page":"5","DOI":"10.21037\/tau.2018.09.11","article-title":"Epidemiology, aetiology and screening of bladder cancer","volume":"8","author":"Cumberbatch","year":"2019","journal-title":"Transl Androl Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2024.01.018_bib0003","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Freddie","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.urolonc.2024.01.018_bib0004","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and Carcinoma in Situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.01.018_bib0005","first-page":"36","article-title":"biological marker","volume":"35","author":"Fang","year":"2001","journal-title":"Chin J Prev Med"},{"issue":"1","key":"10.1016\/j.urolonc.2024.01.018_bib0006","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1101\/gad.949602","article-title":"TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac\/DIABLO","volume":"16","author":"Deng","year":"2002","journal-title":"Genes Dev"},{"issue":"4","key":"10.1016\/j.urolonc.2024.01.018_bib0007","first-page":"1","article-title":"Rapid noninvasive detection of bladder cancer using survivin antibody-conjugated gold nanoparticles (GNPs) based on localized surface plasmon resonance (LSPR)","volume":"69","author":"Jazayeri","year":"2020","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"10.1016\/j.urolonc.2024.01.018_bib0008","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ijc.21000","article-title":"Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis","volume":"116","author":"Steffen","year":"2005","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.urolonc.2024.01.018_bib0009","first-page":"686","article-title":"Meta-analysis","volume":"11","author":"Zhang","year":"2005","journal-title":"Theory Prac Rehabil China"},{"issue":"6","key":"10.1016\/j.urolonc.2024.01.018_bib0010","first-page":"377","article-title":"Clinical significance of urinary exfoliative cell survivin expression in patients with bladder cancer","volume":"25","author":"Cao","year":"2004","journal-title":"Chin J Urol"},{"issue":"8","key":"10.1016\/j.urolonc.2024.01.018_bib0011","first-page":"1276","article-title":"Detection of survivin gene in urinary exfoliated cells from patients with bladder cancer","volume":"7","author":"Pu","year":"2003","journal-title":"China Clin Rehabilitation"},{"issue":"4","key":"10.1016\/j.urolonc.2024.01.018_bib0012","first-page":"351","article-title":"Study of Survivin protein expression in bladder cancer","volume":"29","author":"Zhao","year":"2006","journal-title":"Jo Zunyi Med Coll"},{"issue":"11","key":"10.1016\/j.urolonc.2024.01.018_bib0013","first-page":"839","article-title":"Clinical significance of Survivin expression in urine and cancerous tissues of patients with metastatic epithelial carcinoma of the bladder","volume":"24","author":"Yuan","year":"2009","journal-title":"J Clin Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2024.01.018_bib0014","first-page":"570","article-title":"Expression of Survivin mRNA in urinary exfoliated cells from patients with bladder metastatic cell carcinoma","volume":"22","author":"Zeng","year":"2005","journal-title":"Chin J Exp Surg"},{"issue":"1","key":"10.1016\/j.urolonc.2024.01.018_bib0015","first-page":"87","article-title":"Clinical evaluation of urinary survivin and NMP22 for the diagnosis of bladder metastatic cell carcinoma","volume":"27","author":"Luo","year":"2007","journal-title":"Basic Med Clin"},{"issue":"8","key":"10.1016\/j.urolonc.2024.01.018_bib0016","first-page":"489","article-title":"Detection of expression and significance of survivin in urine exfoliated cells of patients with bladder cancer","volume":"19","author":"Wang","year":"2004","journal-title":"J Clin Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.01.018_bib0017","first-page":"43","article-title":"Clinical analysis of detection of urinary survivin protein as an aid in the diagnosis of bladder metastatic cell carcinoma","volume":"8","author":"Wei","year":"2006","journal-title":"Chin J Mod Med"},{"issue":"4","key":"10.1016\/j.urolonc.2024.01.018_bib0018","first-page":"213","article-title":"Clinical application of combined detection of urinary bladder cancer antigen and survivin for the diagnosis of bladder cancer","volume":"4","author":"Pu","year":"2012","journal-title":"J Mod Urogenital Oncol"},{"issue":"3","key":"10.1016\/j.urolonc.2024.01.018_bib0019","first-page":"166","article-title":"Clinical application of combined detection of Survivin and MUC7 in urine in the diagnosis of bladder cancer","volume":"13","author":"Lin","year":"2019","journal-title":"Chin J Lumpectomy Urol"},{"issue":"44","key":"10.1016\/j.urolonc.2024.01.018_bib0020","first-page":"3520","article-title":"The value of combined test for urinary Livin and Survivin mRNA expression in the early diagnosis of bladder cancer","volume":"93","author":"Jiang","year":"2013","journal-title":"Chin Med J (Engl)"},{"issue":"5","key":"10.1016\/j.urolonc.2024.01.018_bib0021","first-page":"781","article-title":"Combined urinary telomerase survivin and CK19 assay in the early diagnosis of bladder cancer","volume":"25","author":"Lv","year":"2013","journal-title":"West Med"},{"issue":"5","key":"10.1016\/j.urolonc.2024.01.018_bib0022","first-page":"770","article-title":"Clinical value of urinary cyclooxygenase-2 protein and survivin protein in the diagnosis of metastatic cell carcinoma of the bladder","volume":"24","author":"Xu","year":"2008","journal-title":"J Pract Med"},{"issue":"4","key":"10.1016\/j.urolonc.2024.01.018_bib0023","first-page":"203","article-title":"The value of Survivin expression in urine and cancerous tissues for early diagnosis of bladder cancer","volume":"11","author":"Yuan","year":"2006","journal-title":"J Mod Urol"},{"issue":"11","key":"10.1016\/j.urolonc.2024.01.018_bib0024","first-page":"1162","article-title":"Clinical significance of Survivin mRNA level and hyaluronic acid content measurement in the diagnosis and prognosis of bladder metastatic cell carcinoma","volume":"27","author":"Jiang","year":"2006","journal-title":"Sichuan Med"},{"issue":"1","key":"10.1016\/j.urolonc.2024.01.018_bib0025","first-page":"116","article-title":"The value of urine Survivin and Cox-2 protein tests for the early diagnosis of bladder cancer","volume":"23","author":"Jiang","year":"2010","journal-title":"J Radiat Immunol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.01.018_bib0026","first-page":"99","article-title":"The value of urine survivin test combined with exfoliative cell examination in the diagnosis of bladder cancer","volume":"35","author":"Jiang","year":"2008","journal-title":"Fudan J"},{"issue":"14","key":"10.1016\/j.urolonc.2024.01.018_bib0027","first-page":"66","article-title":"Combined urinary survivin, NMP22 and exfoliated cells in the diagnosis of bladder metastatic cell carcinoma","volume":"52","author":"Kang","year":"2012","journal-title":"Shandong Med"},{"issue":"19","key":"10.1016\/j.urolonc.2024.01.018_bib0028","first-page":"112","article-title":"Diagnostic value of urinary Cox-2 protein, Survivin mRNA and exfoliative cytology for migratory cell carcinoma of the bladder","volume":"48","author":"Li","year":"2008","journal-title":"Shandong Med"},{"issue":"11","key":"10.1016\/j.urolonc.2024.01.018_bib0029","first-page":"1211","article-title":"Diagnostic value of urine survivin combined with liquid-based cytology test for bladder cancer","volume":"29","author":"Liang","year":"2016","journal-title":"J Grad Med Sci"},{"issue":"12","key":"10.1016\/j.urolonc.2024.01.018_bib0030","first-page":"48","article-title":"Diagnostic value of urinary survivin test for migratory cell carcinoma of the bladder","volume":"47","author":"Lin","year":"2007","journal-title":"Shandong Med"},{"issue":"9","key":"10.1016\/j.urolonc.2024.01.018_bib0031","first-page":"941","article-title":"Clinical value of urinary Survivin in the diagnosis of metastatic cell carcinoma of the bladder","volume":"8","author":"Ling","year":"2006","journal-title":"Zhejiang Clin Med"},{"issue":"3","key":"10.1016\/j.urolonc.2024.01.018_bib0032","first-page":"365","article-title":"The value of urinary Survivin and NMP22 tests in the early diagnosis of bladder cancer","volume":"33","author":"Liu","year":"2011","journal-title":"Hebei Med"},{"issue":"3","key":"10.1016\/j.urolonc.2024.01.018_bib0033","first-page":"428","article-title":"The value of cytokeratin 20 and survivin in the diagnosis of bladder cancer","volume":"25","author":"Wan","year":"2008","journal-title":"Med Clin Res"},{"issue":"4","key":"10.1016\/j.urolonc.2024.01.018_bib0034","first-page":"233","article-title":"The value of urinary exfoliated cells for the detection of survivin and microchromosomal support protein 5 in the diagnosis of bladder cancer","volume":"26","author":"Zhang","year":"2005","journal-title":"Chin J Urol"},{"issue":"9","key":"10.1016\/j.urolonc.2024.01.018_bib0035","first-page":"1410","article-title":"Clinical value of urinary survivin mRNA for the diagnosis of bladder metastatic cell carcinoma","volume":"23","author":"Wang","year":"2007","journal-title":"J Pract Med"},{"issue":"2","key":"10.1016\/j.urolonc.2024.01.018_bib0036","first-page":"316","article-title":"Expression and clinical relevance of survival proteins in urine exfoliated cells of bladder cancer patients","volume":"24","author":"Xu","year":"2020","journal-title":"Exp Diagn China"},{"issue":"11","key":"10.1016\/j.urolonc.2024.01.018_bib0037","first-page":"680","article-title":"Comparison of the value of survivin and nmp22 for the diagnosis of uroepithelial tumors","volume":"19","author":"Zhang","year":"2004","journal-title":"J Clin Urol"},{"issue":"8","key":"10.1016\/j.urolonc.2024.01.018_bib0038","first-page":"959","article-title":"Detection of Survivin in urinary exfoliated cells from patients with bladder cancer and its clinical application","volume":"23","author":"Wang","year":"2006","journal-title":"Chinese J Exp Surg"},{"issue":"3","key":"10.1016\/j.urolonc.2024.01.018_bib0039","first-page":"121","article-title":"Badr El-Din MO. Value of urinary survivin as a diagnostic marker in bladder cancer","volume":"36","author":"Abd El-Hakim","year":"2014","journal-title":"Anal Quant Cytopathol Histopathol"},{"issue":"3","key":"10.1016\/j.urolonc.2024.01.018_bib0040","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00345-010-0538-2","article-title":"Clinical experience with survivin as a biomarker for urothelial bladder cancer","volume":"28","author":"Marcus","year":"2010","journal-title":"World J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2024.01.018_bib0041","first-page":"121","article-title":"Urinary survivin mRNA expression and urinary nuclear matrix protein 22 BladderChek\u00ae and urine cytology in the detection of transitional cell carcinoma of the bladder. Medical principles and practice: international journal of the Kuwait University","volume":"21","author":"Al-Maghrebi","year":"2012","journal-title":"Health Sci Cent"},{"issue":"6","key":"10.1016\/j.urolonc.2024.01.018_bib0042","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/S0022-5347(06)00254-0","article-title":"Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer","volume":"175","author":"Moussa","year":"2006","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2024.01.018_bib0043","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00432-007-0331-9","article-title":"The value of combined use of survivin, cytokeratin 20 and mucin 7 mRNA for bladder cancer detection in voided urine","volume":"134","author":"Pu","year":"2007","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"10.1016\/j.urolonc.2024.01.018_bib0044","first-page":"7739","article-title":"Combined use of urinary Survivin detection and liquid-based cytology for the early diagnosis of bladder urothelial carcinoma","volume":"15","author":"Xu","year":"2018","journal-title":"Oncol Lett"},{"issue":"8","key":"10.1016\/j.urolonc.2024.01.018_bib0045","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00432-004-0561-z","article-title":"The expression and significance of survivin mRNA in urinary bladder carcinomas","volume":"130","author":"Wang","year":"2004","journal-title":"J Cancer Res Clin Oncol"},{"issue":"13","key":"10.1016\/j.urolonc.2024.01.018_bib0046","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/00029330-200607010-00012","article-title":"Survivin mRNA expression in urine as a biomarker for patients with transitional cell carcinoma of bladder","volume":"119","author":"Hou","year":"2006","journal-title":"Chin Med J (Engl)"},{"issue":"9","key":"10.1016\/j.urolonc.2024.01.018_bib0047","first-page":"647","article-title":"Incidence and mortality of bladder cancer in China, 2014","volume":"40","author":"He","year":"2018","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"3","key":"10.1016\/j.urolonc.2024.01.018_bib0048","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0090-4295(99)80006-5","article-title":"Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations","volume":"45","author":"Messing","year":"1995","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.urolonc.2024.01.018_bib0049","first-page":"182","article-title":"Advances in the study of Survivin in bladder cancer","volume":"11","author":"Cheng","year":"2008","journal-title":"Gen Pract China"},{"issue":"8","key":"10.1016\/j.urolonc.2024.01.018_bib0050","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm0897-917","article-title":"A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma","volume":"3","author":"Ambrosini","year":"1997","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.urolonc.2024.01.018_bib0051","first-page":"2817","article-title":"Detection of survivin expression in bladder cancer and renal cell carcinoma using specific monoclonal antibodies","volume":"39","author":"Chen","year":"2018","journal-title":"Oncol Rep"},{"issue":"9","key":"10.1016\/j.urolonc.2024.01.018_bib0052","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s00345-018-2285-8","article-title":"Diagnostic value of urinary survivin as a biomarker for bladder cancer: a systematic review and meta-analysis of published studies","volume":"36","author":"Liang","year":"2018","journal-title":"World J Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814392400019X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814392400019X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:02:23Z","timestamp":1777608143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107814392400019X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S107814392400019X"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.01.018","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survivin as a potential biomarker in the diagnosis of bladder cancer: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}